Corpay investor plans resale of common stock

Corpay, Inc. filed a notice of proposed resale of common stock.

Rhea-AI Filing Summary

Corpay, Inc. filed a notice of proposed resale of common stock. The securities are to be sold through UBS Financial Services Inc., with trading on the NYSE. The filing also lists prior acquisitions of restricted stock awards from the issuer in multiple years.

These prior acquisitions include common stock received as restricted stock awards on 01/22/2025, 01/23/2024, 01/01/2016, and 05/04/2017, each with specified share amounts.

Key Figures

RSA shares acquired: 1,102 shares RSA shares acquired: 1,497 shares RSA shares acquired: 408 shares +1 more

4 metrics

RSA shares acquired 1,102 shares Restricted stock award of common stock acquired on 01/22/2025 from the issuer

RSA shares acquired 1,497 shares Restricted stock award of common stock acquired on 01/23/2024 from the issuer

RSA shares acquired 408 shares Restricted stock award of common stock acquired on 01/01/2016 from the issuer

RSA shares acquired 2,293 shares Restricted stock award of common stock acquired on 05/04/2017 from the issuer

Key Terms

Form 144, restricted stock awards, RSA, securities exchange

4 terms

Form 144 regulatory

"Corpay, Inc. filed a notice of proposed resale of common stock on Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock awards financial

"prior acquisitions include common stock received as restricted stock awards on 01/22/2025"

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

RSA financial

"Common | 01/22/2025 | RSA | Issuer | | | 1102 | 01/22/2025 | N/A"

securities exchange financial

"shares are expected to be traded on the NYSE securities exchange"

A securities exchange is a regulated marketplace where buyers and sellers trade stocks, bonds and other financial instruments; it acts like an organized auction house that matches orders, shows prices and enforces rules so transactions are fair and visible. For investors it matters because exchanges provide liquidity (the ability to buy or sell quickly), transparent price discovery and oversight that reduce fraud and help determine the market value of holdings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Corpay (CPAY) disclose in this Form 144 filing?

Corpay (CPAY) discloses a planned resale of common stock through UBS Financial Services Inc. It also details earlier restricted stock award acquisitions by the reporting holder from 2016, 2017, 2024, and 2025.

Which broker is involved in the planned CPAY stock sale?

The planned sale of Corpay (CPAY) common stock is arranged through UBS Financial Services Inc. The filing indicates that the shares are expected to be traded on the NYSE as part of this resale process.

What prior restricted stock awards are listed for Corpay (CPAY)?

The filing lists Corpay (CPAY) common shares acquired via restricted stock awards (RSA) on 01/22/2025, 01/23/2024, 01/01/2016, and 05/04/2017, with individual award amounts of 1,102, 1,497, 408, and 2,293 shares respectively.

On which exchange will the CPAY shares in this Form 144 be sold?

The proposed sale of Corpay (CPAY) common stock referenced in this Form 144 is intended for trading on the NYSE. UBS Financial Services Inc. is identified as the broker for effecting these transactions on that exchange.

Does this Corpay (CPAY) Form 144 describe new share issuance?

No. The Corpay (CPAY) Form 144 relates to a resale of existing common shares by a holder. It references previously granted restricted stock awards rather than any new issuance of shares by the company.

What is the significance of the dates listed for CPAY RSAs?

The dates 01/22/2025, 01/23/2024, 01/01/2016, and 05/04/2017 mark when restricted stock awards of Corpay (CPAY) common stock were acquired from the issuer. These awards form part of the holder’s position now being partially registered for resale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/12/2026 - 04:39 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001606223
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Corpay Inc
SEC File Number	001-35004
Address of Issuer	3280 Peachtree Road Suite 2400 Atlanta GEORGIA 30305
Phone	770-449-0479
Name of Person for Whose Account the Securities are To Be Sold	Joseph W. Farrelly
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	5300	2150000	65000000	08/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/22/2025	RSA	Issuer			1102	01/22/2025	N/A
Common	01/23/2024	RSA	Issuer			1497	01/23/2024	N/A
Common	01/01/2016	RSA	Issuer			408	01/01/2016	N/A
Common	05/04/2017	RSA	Issuer			2293	05/04/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Joseph W. Farrelly
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)